You just read:

Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders

News provided by

Intec Pharma Ltd.

02 May, 2019, 14:00 IDT